Related Experiment Videos
The effect of mitomycin C on platelet aggregation and adenosine 3',5'-monophosphate metabolism
Abstract:
The effect of Mitomycin C on aggregation, adenosine 3',5'-monophosphate (cyclic AMP) metabolism and reactions induced by thrombin was studied in rabbit platelets. Mitomycin C inhibited the platelet aggregation induced by adenosine diphosphate or thrombin. The level of radioactive cyclic AMP derived from 8-14C adenine or 8-14C adenosine increased after incubating intact platelets with Mitomycin C. Formation of radioactive adenosine triphosphate also increased though mitochondrial oxidation was not stimulated. Similar effect was observed also in rabbit liver. Mitomycin C failed to stimulate platelet adenyl cyclase but inhibited cyclic AMP phosphodiesterase in the absence of theophylline. In the platelets preincubated with Mitomycin C, thrombin-induced inhibition of adenyl cyclase, stimulation of membrane-bound cyclic AMP phosphodiesterase, and release of 250,000 dalton protein from platelet membranes were prevented. These results suggest that Mitomycin C will affect cellular membrane structure and function, and this extranuclear effect of Mitomycin C will lead to inhibition of aggregation in blood platelets.
Insights
Mitomycin C inhibits platelet aggregation by affecting cellular membrane function, not by directly stimulating adenyl cyclase. This drug impacts cyclic AMP metabolism and prevents thrombin-induced changes in platelets.
Area of Science:
- Biochemistry
- Pharmacology
- Cell Biology
Background:
- Platelet aggregation is crucial for hemostasis and thrombosis.
- Cyclic AMP (adenosine 3',5'-monophosphate) plays a key role in regulating platelet function.
- Thrombin and adenosine diphosphate are potent inducers of platelet aggregation.
Purpose of the Study:
- To investigate the effects of Mitomycin C on rabbit platelet aggregation.
- To elucidate the impact of Mitomycin C on cyclic AMP metabolism in platelets.
- To determine the mechanism by which Mitomycin C influences thrombin-induced platelet activation.
Main Methods:
- Studied Mitomycin C's effect on platelet aggregation induced by adenosine diphosphate and thrombin.
- Measured changes in radioactive cyclic AMP and adenosine triphosphate levels.
- Assessed the activity of platelet adenyl cyclase and cyclic AMP phosphodiesterase.
- Examined the influence of Mitomycin C on thrombin-induced alterations in platelet membranes.
Main Results:
- Mitomycin C inhibited platelet aggregation induced by both adenosine diphosphate and thrombin.
- Increased levels of radioactive cyclic AMP and adenosine triphosphate were observed in platelets treated with Mitomycin C.
- Mitomycin C inhibited cyclic AMP phosphodiesterase but did not stimulate adenyl cyclase.
- Preincubation with Mitomycin C prevented thrombin-induced inhibition of adenyl cyclase and stimulation of phosphodiesterase.
Conclusions:
- Mitomycin C affects platelet cellular membrane structure and function.
- The extranuclear effects of Mitomycin C lead to the inhibition of blood platelet aggregation.
- Mitomycin C modulates cyclic AMP metabolism, contributing to its anti-aggregatory properties.